AU
Nuo Therapeutics, Inc.
AURX · OTC
$1.30 +4.83% (+$0.06)
1M +21.50%
Market Cap $62.9M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 12.10x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 209.05%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 38.70%
Op. margin 33.32%
FCF margin 47.06%
Quality
21 /100
Poor ROA 76.63%
Asset turnover 1.98x
ROIC 153.00%
Debt
24 /100
High Int. coverage -25.05x
Current ratio 1.28x
Net debt/EBITDA N/A
Stability
40 /100
Moderate Rev. volatility 178.40%
EPS volatility 19.63%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o AURX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David E. Jorden
Employees
10
Headquarters
Houston
Nadchodzące wydarzenia
02 GRU
Earnings
Upcoming earnings report